Our mission is to become a transnational pharmaceutical company through the development and introduction of a wide portfolio of branded and generic products in key markets.
Lupin Pharmaceuticals, Inc. entered the U.S. generic pharmaceutical market in 2003 with the ANDA approval for cefuroxime axetil.
We are very pleased to be able to bring Suprax® an important anti-infective product in pediatric practice, back to the US market.
We are recognized as a leading manufacturer of cephalosporin API’s, with FDA approval to manufacture complex oral and injectable cephalosporins.
For Aerochamber Plus® information, go to the following website link:
Lupin is amongst the world's largest manufacturers of products in its chosen therapeutic areas.
Lupin receives FDA approval for its Oral Contraceptive Pirmella™ 7/7/7 and Pirmella™ 1/35 Tablets
Lupin announces favorable ruling for generic Yaz® Oral Contraceptive Tablets
Lupin launches its Oral Contraceptive Daysee
Tablets in the US Market Generic of Seasonique® Tablets
Lupin Launches Generic Diovan HCT® Tablets
Lupin to launch Generic Yasmin® Tablets; receives FDA approval
Lupin launches Generic TRICOR® Tablets
manufacturing / r&d
Copyright © 2010, Lupin Pharmaceuticals, Inc., All Rights Reserved.
Created and Designed by